Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005

Journal of Clinical Microbiology

Volumn 45, Issue 8, 2007, Pages 2704-2707

  Schlievert, Patrick M ^a   Case, Laura C ^a   Strandberg, Kristi L ^a   Tripp, Timothy J ^a   Lin, Ying Chi ^b   Peterson, Marnie L ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROTOXIN LIKE SUPERANTIGEN K; ENTEROTOXIN LIKE SUPERANTIGEN L; ENTEROTOXIN LIKE SUPERANTIGEN M; ENTEROTOXIN LIKE SUPERANTIGEN N; ENTEROTOXIN LIKE SUPERANTIGEN Q; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN G; STAPHYLOCOCCUS ENTEROTOXIN I; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN DETECTION; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; TAMPON; TOXIC SHOCK SYNDROME; UTERINE CERVIX CAP; VAGINA FLORA;

ANTIGENS, BACTERIAL; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MENSTRUAL HYGIENE PRODUCTS; MINNESOTA; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TIME FACTORS; VAGINA; VIRULENCE FACTORS;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 34548059223     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02295-06     Document Type: Article

References (40)

1. American College of Obstetricians and Gynecologists. 2006. ACOG committee opinion: no. 345, October 2006; vulvodynia. Obstet. Gynecol. 108: 1049-1052.
2. Andreu, A., A. E. Stapleton, C. L. Fennell, S. L. Hillier, and W. E. Stamm. 1995. Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. J. Infect. Dis. 171:1237-1243.
3. Baehler, E. A., W. P. Dillon, D. M. Dryja, and E. Neter. 1983. The effects of prolonged retention of diaphragms on colonization by Staphylococcus aureus of the lower genital tract. Fertil. Steril. 39:162-166.
4. Bergdoll, M. S., B. A. Crass, R. F. Reiser, R. N. Robbins, and J. P. Davis. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet i:1017-1021.
5. Chow, A. W., K. H. Bartlett, R. Percival-Smith, and B. J. Morrison. 1984. Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J. Infect. Dis. 150: 80-84.
6. Davis, J. P., P. J. Chesney, P. J. Wand, and M. LaVenture. 1980. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303:1429-1435.
7. Diep, B. A., S. R. Gill, R. F. Chang, T. H. Phan, J. H. Chen, M. G. Davidson, F. Lin, J. Lin, H. A. Carleton, E. F. Mongodin, G. F. Sensabaugh, and F. Perdreau-Remington. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367:731-739.
8. Fitzgerald, J. R., S. R. Monday, T. J. Foster, G. A. Bohach, P. J. Hartigan, W. J. Meaney, and C. J. Smyth. 2001. Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple super-antigens. J. Bacteriol. 183:63-70.
9. Gaventa, S., A. L. Reingold, A. W. Hightower, C. V. Broome, B. Schwartz, C. Hoppe, J. Harwell, L. K. Lefkowitz, S. Makintubee, D. R. Cundiff, et al. 1989. Active surveillance for toxic shock syndrome in the United States, 1986. Rev. Infect. Dis. 11(Suppl. 1):S28-S34.
10. Gupta, K., S. L. Hillier, T. M. Hooton, P. L. Roberts, and W. E. Stamm. 2000. Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J. Infect. Dis. 181:595-601.
11. Jarraud, S., G. Cozon, F. Vandenesch, M. Bes, J. Etienne, and G. Lina. 1999. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J. Clin. Microbiol. 37:2446-2449.
12. Jarraud, S., M. A. Peyrat, A. Lim, A. Tristan, M. Bes, C. Mougel, J. Etienne, F. Vandenesch, M. Bonneville, and G. Lina. 2001. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J. Immunol. 166:669-677.
13. Kass, E. H., M. I. Kendrick, Y. C. Tsai, and J. Parsonnet. 1987. Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J. Infect. Dis. 155: 812-815.
14. 2-generating lac-tobacilli. J. Infect. Dis. 164:94-100.
15. Larsen, B., and R. P. Galask. 1982. Vaginal microbial flora: composition and influences of host physiology. Ann. Intern. Med. 96:926-930.
16. Lina, G., G. A. Bohach, S. P. Nair, K. Hiramatsu, E. Jouvin-Marche, and R. Mariuzza. 2004. Standard nomenclature for the superantigens expressed by Staphylococcus. J. Infect. Dis. 189:2334-2336.
17. Lindsay, J. A., A. Ruzin, H. F. Ross, N. Kurepina, and R. P. Novick. 1998. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol. Microbiol. 29:527-543.
18. Linnemann, C. C., Jr., J. L. Staneck, S. Hornstein, T. P. Barden, J. L. Rauh, P. F. Bonventre, C. R. Buncher, and A. Beiting. 1982. The epidemiology of genital colonization with Staphylococcus aureus. Ann. Intern. Med. 96:940-944.
19. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
20. McCormick, J. K., J. M. Yarwood, and P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:77-104.
21. Newbern, E. C., B. Foxman, D. Leaman, and J. D. Sobel. 2002. Desquamative inflammatory vaginitis: an exploratory case-control study. Ann. Epidemiol. 12:346-352.
22. Ohm, M. J., and R. P. Galask. 1975. The effect of antibiotic prophylaxis on patients undergoing vaginal operations. II. Alterations of microbial flora. Am. J. Obstet Gynecol. 123:597-604.
23. Onderdonk, A. B., M. L. Delaney, G. R. Zamarchi, M. L. Hirsch, A. Munoz, and E. H. Kass. 1989. Normal vaginal microflora during use of various forms of catamenial protection. Rev. Infect. Dis. 11(Suppl. 1):S61-S67.
24. Onderdonk, A. B., G. R. Zamarchi, M. L. Rodriguez, M. L. Hirsch, A. Munoz, and E. H. Kass. 1987. Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl. Environ. Microbiol. 53:2774-2778.
25. Onderdonk, A. B., G. R. Zamarchi, J. A. Walsh, R. D. Mellor, A. Munoz, and E. H. Kass. 1986. Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation. Appl. Environ. Microbiol. 51:333-339.
26. Parsonnet, J., M. A. Hansmann, M. L. Delaney, P. A. Modern, A. M. Dubois, W. Wieland-Alter, K. W. Wissemann, J. E. Wild, M. B. Jones, J. L. Seymour, and A. B. Onderdonk. 2005. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this super-antigen in menstruating women. J. Clin. Microbiol. 43:4628-4634.
27. Schlievert, P. M. 1998. Effect of contraceptive diaphragms on production of TSST-1. Int. Congr. Symp. Ser. 229:128-130.
28. Schlievert, P. M. 1996. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins. J. Am. Coll Surg. 183:19-24.
29. Schlievert, P. M., and D. A. Blomster. 1983. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect. Dis. 147:236-242.
30. Schlievert, P. M., and J. A. Kelly. 1984. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J. Infect. Dis. 149:471.
31. Schlievert, P. M., M. T. Osterholm, J. A. Kelly, and R. D. Nishimura. 1982. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann. Intern. Med. 96:937-940.
32. Schlievert, P. M., K. N. Shands, B. B. Dan, G. P. Schmid, and R. D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143:509-516.
33. Schlievert, P. M., T. J. Tripp, and M. L. Peterson. 2004. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J. Clin. Microbiol. 42:2875-2876.
34. Schwartz, B., S. Gaventa, C. V. Broome, A. L. Reingold, A. W. Hightower, J. A. Perlman, and P. H. Wolf. 1989. Nonmenstrual toxic shock syndrome associated with barrier contraceptives: report of a case-control study. Rev. Infect. Dis. 11:S43-S48.
35. Shands, K. N., G. P. Schmid, B. B. Dan, D. Blum, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. V. Broome, J. D. Band, and D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303:1436-1442.
36. Sobel, J. D. 1994. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am. J. Obstet. Gynecol. 171:1215-1220.
37. Sumby, P., and M. K. Waldor. 2003. Transcription of the toxin genes present within the Staphylococcal phage phiSa3ms is intimately linked with the phage's life cycle. J. Bacteriol. 185:6841-6851.
38. Veeh, R. H., M. E. Shirtliff, J. R. Petik, J. A. Flood, C. C. Davis, J. L. Seymour, M. A. Hansmann, K. M. Kerr, M. E. Pasmore, and J. W. Costerton. 2003. Detection of Staphylococcus aureus biofilm on tampons and menses components. J. Infect. Dis. 188:519-530.
39. Wagner, G., L. Bohr, P. Wagner, and L. N. Petersen. 1984. Tampon-induced changes in vaginal oxygen and carbon dioxide tensions. Am. J. Obstet. Gynecol. 148:147-150.
40. Wagner, G., R. J. Levin, and L. Bohr. 1988. Diaphragm insertion increases human vaginal oxygen tension. Am. J. Obstet. Gynecol. 158:1040-1043.